Predictors of residual mass requiring surgical resection after chemotherapy of stage III testicular cancer A prospective study
- 31 July 1992
- Vol. 40 (1) , 7-8
- https://doi.org/10.1016/0090-4295(92)90427-x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Histology of Tumor Residuals Following Chemotherapy in Patients with Advanced Nonseminomatous Testicular CancerJournal of Urology, 1989
- Teratoma Following Cisplatin-Based Combination Chemotherapy for Nonseminomatous Germ Cell Tumors: A Clinicopathological CorrelationJournal of Urology, 1986
- Prognostic Factors in Non Semin Omatous Testicular CancerJournal of Urology, 1986
- Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimenCancer, 1983
- A randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage III testicular cancer with poor prognostic featuresCancer, 1982